Psoriasis trials recruiting in Massachusetts

All Psoriasis trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
  NCT05744466 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Waltham
• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
  NCT06888193 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · Massachusetts: Boston
• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
  NCT06807424 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Brookline
• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
  NCT06979453 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Massachusetts: Milford
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Brighton
• An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
  NCT07449702 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
  NCT06100991 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Waltham
• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
  NCT07474792 · Phase: Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Massachusetts: Boston, Milford
• Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
  NCT05669833 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Massachusetts: Worcester
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · Massachusetts: Brighton, Milford, Quincy
• Multi-Center PAMPA Study
  NCT05004727 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
  NCT02418442 · Phase: Not specified · Ages: Up to 21 Years · Sex: All (male and female) · Massachusetts: Boston, Springfield
• PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
  NCT07648602 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Waltham
• PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
  NCT07615712 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Waltham
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• The CorEvitas Psoriasis (PSO) Registry
  NCT02707341 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Waltham